First reported at 214,270 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 10345000 |
| 2021-12-31 | 9542000 |
| 2022-03-31 | 0 |
| 2022-06-30 | 14491000 |
| 2022-09-30 | 22282000 |
| 2022-12-31 | 18681619 |
| 2023-03-31 | 10042750 |
| 2023-06-30 | 8457768 |
| 2023-09-30 | 6538829 |
| 2023-12-31 | 5832000 |
| 2024-03-31 | 0 |
| 2026-03-31 | 2867613 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -122,600 (-100.0%) | 0 | $0 | 2026-08-13 | |
| Q1 2026 | New | 122,600 | +122,600 (0.0%) | 0.36% | $2,867,613 | 2026-05-14 | |
| Q1 2024 | Reduced | 0 | -75,000 (-100.0%) | 0 | $0 | 2024-05-14 | |
| Q4 2023 | Reduced | 75,000 | -18,000 (-19.4%) | 0.78% | $5,832,000 | 2024-02-13 | |
| Q3 2023 | Reduced | 93,000 | -13,200 (-12.4%) | 0.86% | $6,538,829 | 2023-11-13 | |
| Q2 2023 | Reduced | 106,200 | -32,800 (-23.6%) | 0.85% | $8,457,768 | 2023-08-11 | |
| Q1 2023 | Reduced | 139,000 | -87,939 (-38.8%) | 1.48% | $10,042,750 | 2023-05-12 | |
| Q4 2022 | Reduced | 226,939 | -58,061 (-20.4%) | 2.69% | $18,681,619 | 2023-02-13 | |
| Q3 2022 | Added | 285,000 | +70,730 (33.0%) | 1.89% | $22,282,000 | 2022-11-14 | |
| Q2 2022 | New | 214,270 | +214,270 (0.0%) | 1.63% | $14,491,000 | 2022-08-12 | |
| Q1 2022 | Reduced | 0 | -157,200 (-100.0%) | 0 | $0 | 2022-05-13 | |
| Q4 2021 | Reduced | 157,200 | -5,000 (-3.1%) | 0.67% | $9,542,000 | 2022-02-11 | |
| Q3 2021 | Added | 162,200 | +21,200 (15.0%) | 0.62% | $10,345,000 | 2021-11-12 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
314 managers reported ACADIA HEALTHCARE COMPANY I for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 10,450,502 | -148,251 | 0.09% | $706,767,000 | 37 qtrs |
| VANGUARD GROUP INC | Added | 8,626,045 | +196,198 | 0.02% | $583,380,000 | 37 qtrs |
| BlackRock Inc | Added | 7,655,210 | +152,098 | 0.02% | $517,722,000 | 37 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 5,072,224 | -187,679 | 0.12% | $343,043,000 | 37 qtrs |
| JPMorgan Chase & Co | Added | 4,026,376 | +360 | 0.04% | $272,304,000 | 37 qtrs |
| WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | Reduced | 3,769,631 | -289,533 | 0.94% | $254,940,000 | 7 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 3,749,982 | -1,089,965 | 0.05% | $253,612,000 | 37 qtrs |
| VIKING GLOBAL INVESTORS LP | Added | 3,478,476 | +1,348,043 | 1.08% | $235,249,000 | 7 qtrs |
| Invesco Ltd | Added | 3,128,398 | +1,335,490 | 0.06% | $211,573,000 | 37 qtrs |
| ALLIANCEBERNSTEIN L P | Reduced | 2,501,258 | -266,570 | 0.08% | $169,160,000 | 37 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 12, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 214,270
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.